Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung CancerTony Mok, Vassiliki A. Papadimitrakopoulou, Frances A. Shepherd et al.|New England Journal of Medicine|2016Cited by 3.3k
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trialsJames Chih‐Hsin Yang, Lecia V. Sequist, Yi‐Long Wu et al.|The Lancet Oncology|2015Cited by 1.6k
Prävention, Diagnostik, Therapie und Nachsorge des LungenkarzinomsWolfgang Schütte, Dag Wormanns, S Gütz et al.|Pneumologie|2023Cited by 9